Novocure (NSDQ:NVCR) shares took a dive today on second-quarter results that came up short of the consensus forecast.
NVCR shares were down -11.7% at $160.67 in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.9% on the day.
Get the full story at our sister site, Drug Delivery Business News.